Haemonetics Cash on Hand 2010-2023 | HAE

Haemonetics cash on hand from 2010 to 2023. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Haemonetics Annual Cash on Hand
(Millions of US $)
2023 $284
2022 $259
2021 $192
2020 $137
2019 $169
2018 $180
2017 $140
2016 $115
2015 $161
2014 $192
2013 $179
2012 $229
2011 $197
2010 $142
2009 $157
Haemonetics Quarterly Cash on Hand
(Millions of US $)
2023-12-31 $194
2023-09-30 $351
2023-06-30 $286
2023-03-31 $284
2022-12-31 $224
2022-09-30 $241
2022-06-30 $215
2022-03-31 $259
2021-12-31 $237
2021-09-30 $192
2021-06-30 $173
2021-03-31 $192
2020-12-31 $189
2020-09-30 $279
2020-06-30 $276
2020-03-31 $137
2019-12-31 $126
2019-09-30 $112
2019-06-30 $190
2019-03-31 $169
2018-12-31 $155
2018-09-30 $200
2018-06-30 $192
2018-03-31 $180
2017-12-31 $252
2017-09-30 $204
2017-06-30 $172
2017-03-31 $140
2016-12-31 $130
2016-09-30 $139
2016-06-30 $118
2016-03-31 $115
2015-12-31 $105
2015-09-30 $100
2015-06-30 $112
2015-03-31 $161
2014-12-31 $125
2014-09-30 $130
2014-06-30 $140
2014-03-31 $192
2013-12-31 $178
2013-09-30 $159
2013-06-30 $166
2013-03-31 $179
2012-12-31 $193
2012-09-30 $187
2012-06-30 $236
2012-03-31 $229
2011-12-31 $205
2011-09-30 $183
2011-06-30 $217
2011-03-31 $197
2010-12-31 $170
2010-09-30 $115
2010-06-30 $83
2010-03-31 $142
2009-12-31 $169
2009-09-30 $178
2009-06-30 $174
2009-03-31 $157
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $4.311B $1.169B
Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $183.756B 24.12
Stryker (SYK) United States $127.849B 31.70
Medtronic (MDT) Ireland $105.004B 14.86
Boston Scientific (BSX) United States $99.704B 33.15
EssilorLuxottica (ESLOY) France $97.123B 0.00
Lonza Group Ag (LZAGY) Switzerland $42.671B 0.00
Haleon (HLN) United Kingdom $37.031B 28.96
ResMed (RMD) United States $25.568B 25.56
Zimmer Biomet Holdings (ZBH) United States $24.922B 16.05
Terumo (TRUMY) Japan $24.880B 35.14
Baxter (BAX) United States $20.069B 14.64
Koninklijke Philips (PHG) Netherlands $18.712B 14.93
Insulet (PODD) United States $11.642B 61.12
Smith & Nephew SNATS (SNN) United Kingdom $10.457B 0.00
Demant (WILYY) Denmark $10.001B 0.00
Bio-Rad Laboratories (BIO) United States $8.295B 24.71
BellRing Brands (BRBR) United States $7.115B 38.25
Lantheus Holdings (LNTH) United States $4.215B 10.88
Perrigo (PRGO) Ireland $4.071B 11.64
GN Store Nord (GNNDY) Denmark $3.675B 23.80
Prestige Consumer Healthcare (PBH) United States $3.378B 15.97
Envista Holdings (NVST) United States $3.367B 12.80
Green Thumb Industries (GTBIF) United States $2.758B 87.40
Neogen (NEOG) United States $2.630B 25.29
QuidelOrtho (QDEL) United States $2.589B 9.40
ICU Medical (ICUI) United States $2.336B 17.43
TG Therapeutics (TGTX) United States $2.134B 691.00
Maravai LifeSciences Holdings (MRVI) United States $1.943B 0.00
Verano Holdings (VRNOF) United States $1.858B 0.00
Owens & Minor (OMI) United States $1.836B 17.62
Agios Pharmaceuticals (AGIO) United States $1.631B 0.00
National Vision Holdings (EYE) United States $1.486B 46.29
InMode (INMD) Israel $1.465B 7.59
LeMaitre Vascular (LMAT) United States $1.415B 46.70
AdaptHealth (AHCO) United States $1.253B 9.43
Warby Parker (WRBY) United States $1.189B 0.00
AtriCure (ATRC) United States $1.134B 0.00
MacroGenics (MGNX) United States $1.007B 0.00
Cresco Labs (CRLBF) United States $0.757B 0.00
VAREX IMAGING (VREX) United States $0.687B 14.83
BioLife Solutions (BLFS) United States $0.686B 0.00
Evolus (EOLS) United States $0.674B 0.00
Jin Medical (ZJYL) China $0.631B 0.00
Quanterix (QTRX) United States $0.602B 0.00
Canopy Growth (CGC) Canada $0.591B 0.00
Valneva SE (VALN) France $0.538B 0.00
TerrAscend (TSNDF) Canada $0.533B 0.00
Phibro Animal Health (PAHC) United States $0.521B 11.29
PetIQ (PETQ) United States $0.469B 17.50
ZimVie (ZIMV) United States $0.417B 25.55
Biote (BTMD) United States $0.411B 3.91
OraSure Technologies (OSUR) United States $0.402B 6.65
Zynex (ZYXI) United States $0.388B 44.70
Surmodics (SRDX) United States $0.378B 40.80
Aurora Cannabis (ACB) Canada $0.316B 0.00
Viemed Healthcare (VMD) United States $0.303B 30.08
Cerus (CERS) United States $0.297B 0.00
Sanara MedTech (SMTI) United States $0.272B 0.00
TriSalus Life Sciences (TLSI) United States $0.256B 0.00
Utah Medical Products (UTMD) United States $0.243B 14.80
Ayr Wellness (AYRWF) United States $0.210B 0.00
Omeros (OMER) United States $0.194B 0.00
Organigram Holdings (OGI) Canada $0.189B 0.00
High Tide (HITI) Canada $0.178B 0.00
Capricor Therapeutics (CAPR) United States $0.175B 0.00
Veru (VERU) United States $0.170B 0.00
Quipt Home Medical (QIPT) United States $0.154B 0.00
Jushi Holdings (JUSHF) United States $0.138B 0.00
FitLife Brands (FTLF) United States $0.136B 21.93
Eagleford Energy (GRUSF) United States $0.135B 68.05
InterCure (INCR) Israel $0.108B 18.15
Fonar (FONR) United States $0.105B 8.98
Allurion Technologies (ALUR) United States $0.104B 0.00
Cellectar Biosciences (CLRB) United States $0.104B 0.00
MariMed (MRMD) United States $0.101B 0.00
Safety Shot (SHOT) United States $0.097B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.094B 0.00
Brainsway (BWAY) Israel $0.084B 0.00
Chimerix (CMRX) United States $0.081B 0.00
Zevia PBC (ZVIA) United States $0.073B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.057B 3.72
Apyx Medical (APYX) United States $0.046B 0.00
Rockwell Medical (RMTI) United States $0.043B 0.00
Cytosorbents (CTSO) United States $0.043B 0.00
Bright Green (BGXX) United States $0.041B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Modular Medical (MODD) United States $0.037B 0.00
United-Guardian (UG) United States $0.036B 14.04
Exagen (XGN) United States $0.024B 0.00
Nephros (NEPH) United States $0.021B 0.00
Flora Growth (FLGC) United States $0.019B 0.00
GlucoTrack (GCTK) United States $0.019B 0.00
FSD PHARMA (HUGE) Canada $0.018B 0.00
Agape ATP (ATPC) $0.018B 0.00
Meihua Medical Technologies (MHUA) China $0.015B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
GUARDION HEALTH (GHSI) United States $0.010B 73.36
ProSomnus (OSA) United States $0.008B 0.00
IM Cannabis (IMCC) Canada $0.008B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Senestech (SNES) United States $0.004B 0.00
Innovative Eyewear (LUCY) United States $0.003B 0.00
Lucy Scientific Discovery (LSDI) Canada $0.002B 0.00
Akanda (AKAN) United Kingdom $0.001B 0.00
Smart For Life (SMFL) United States $0.000B 0.00
Bruush Oral Care (BRSH) $0.000B 0.00
SNDL (SNDL) Canada $0.000B 0.00